Clinical trial
A Double-blind Randomized Placebo Controlled Trial of Rabeprazole for Prevention of NSAID-associated Dyspepsia and Gastroduodenal Injury
NCT01140828 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-blind Randomized Placebo Controlled Trial of Rabeprazole for Prevention of NSAID-associated Dyspepsia and Gastroduodenal Injury
- Lead sponsor
- Chinese University of Hong Kong
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 31, 2009
- Completion date
- June 30, 2015
- Enrollment
- 112 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.